Compare WAL & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAL | RGEN |
|---|---|---|
| Founded | 1994 | 1981 |
| Country | United States | United States |
| Employees | 3524 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.1B |
| IPO Year | N/A | 1995 |
| Metric | WAL | RGEN |
|---|---|---|
| Price | $68.28 | $114.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 11 |
| Target Price | $98.40 | ★ $173.09 |
| AVG Volume (30 Days) | ★ 1.7M | 788.0K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | ★ 2.41% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | N/A | ★ 0.86 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | $20.16 | $14.11 |
| Revenue Next Year | $8.63 | $14.71 |
| P/E Ratio | ★ $10.88 | $138.80 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $57.05 | $102.97 |
| 52 Week High | $97.23 | $175.77 |
| Indicator | WAL | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 24.70 | 29.03 |
| Support Level | N/A | $113.07 |
| Resistance Level | $89.70 | $132.51 |
| Average True Range (ATR) | 3.68 | 6.60 |
| MACD | -1.95 | -0.40 |
| Stochastic Oscillator | 3.45 | 9.23 |
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.